Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of BE818333ApublicationCriticalpatent/BE818333A/fr
C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
BE147153A1973-08-011974-07-31Cycloserines n-substituees et procede pour les fabriquer
BE818333A
(fr)
Nouveaux composés appartenant à la famille des benzoyl- et alpha-hydroxybenzyl-phényl-osides, leur procédé de préparation et leur application en thérapeutique
5a-cholestane-3b, 22s-diols substitues en position 25 et leurs esters, et leurs utilisations therapeutiques en tant qu'inhibiteurs de la biosynthese du cholesterol